Young Comments on New Government Requirements On Duke University Researchers Who Receive Federal Funds
March 23, 2018
Science Magazine
Senior Counsel Torrey Young is quoted in a Science magazine article, “Duke’s mishandling of misconduct prompts new U.S. government grant oversight,” about new National Institutes of Health requirements on university-based research in response to concerns about the institution’s handling of recent research misconduct and grant management cases.
Young, who has represented a number of institutions in matters involving research misconduct and grants accounting, said she believes the action is a “fairly rare and extensive” move on the NIH’s part.
“These additional administrative burdens potentially could delay funding and extensions, as well as significantly increase duties for Duke’s Office of Research Support,” she said. “This may also lead to reputational harm to the institution, leading to difficulty recruiting researchers.”
Young, who has represented a number of institutions in matters involving research misconduct and grants accounting, said she believes the action is a “fairly rare and extensive” move on the NIH’s part.
“These additional administrative burdens potentially could delay funding and extensions, as well as significantly increase duties for Duke’s Office of Research Support,” she said. “This may also lead to reputational harm to the institution, leading to difficulty recruiting researchers.”
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."